{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:57:15Z","timestamp":1790351835607,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-021-00454-y","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T17:03:56Z","timestamp":1616173436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma"],"prefix":"10.1038","volume":"11","author":[{"given":"Kalyan","family":"Nadiminti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hasib","family":"Sidiqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Meleveedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3609-8404","authenticated-orcid":false,"given":"Hassan B.","family":"Alkhateeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5841-4105","authenticated-orcid":false,"given":"William J.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-6302","authenticated-orcid":false,"given":"Mark","family":"Litzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6998-662X","authenticated-orcid":false,"given":"Mrinal","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-9284","authenticated-orcid":false,"given":"Shaji","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3853-5196","authenticated-orcid":false,"given":"Morie","family":"Gertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5359-336X","authenticated-orcid":false,"given":"Mithun Vinod","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"454_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1182\/blood-2018-08-825349","volume":"133","author":"SK Kumar","year":"2019","unstructured":"Kumar, S. K., Buadi, F. K. & Rajkumar, S. V. Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing. Blood 133, 652\u2013659 (2019).","journal-title":"Blood"},{"key":"454_CR2","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1056\/NEJMoa1402551","volume":"371","author":"L Benboubker","year":"2014","unstructured":"Benboubker, L. et al. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma. N. Engl. J. Med. 371, 906\u2013917 (2014).","journal-title":"N. Engl. J. Med."},{"key":"454_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.leukres.2018.07.016","volume":"74","author":"T Radivoyevitch","year":"2018","unstructured":"Radivoyevitch, T. et al. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. Leukemia Res. 74, 130\u2013136 (2018).","journal-title":"Leukemia Res."},{"key":"454_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S1470-2045(13)70609-0","volume":"15","author":"A Palumbo","year":"2014","unstructured":"Palumbo, A. et al. Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data. Lancet Oncol. 15, 333\u2013342 (2014).","journal-title":"Lancet Oncol."},{"key":"454_CR5","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1056\/NEJMoa1114083","volume":"366","author":"PL McCarthy","year":"2012","unstructured":"McCarthy, P. L. et al. Lenalidomide after stem-cell transplantation for multiple myeloma. N. Engl. J. Med. 366, 1770\u20131781 (2012).","journal-title":"N. Engl. J. Med."},{"key":"454_CR6","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1056\/NEJMoa1114138","volume":"366","author":"M Attal","year":"2012","unstructured":"Attal, M. et al. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma. New England J. Med. 366, 1782\u20131791 (2012).","journal-title":"New England J. Med."},{"key":"454_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16805-5","volume":"11","author":"TH Mouhieddine","year":"2020","unstructured":"Mouhieddine, T. H. et al. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Nat. Commun. 11, 2996 (2020).","journal-title":"Nat. Commun."},{"key":"454_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.clml.2014.07.001","volume":"15","author":"N Pemmaraju","year":"2015","unstructured":"Pemmaraju, N. et al. Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia. Clin. Lymphoma Myeloma Leuk. 15, 110\u2013114 (2015).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"454_CR9","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3109\/10428194.2014.970543","volume":"56","author":"MA Gertz","year":"2015","unstructured":"Gertz, M. A. et al. Therapy-related myelodysplastic syndrome\/acute leukemia after multiple myeloma in the era of novel agents. Leuk. Lymphoma 56, 1723\u20131726 (2015).","journal-title":"Leuk. Lymphoma"},{"key":"454_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1309\/AJCPRKYAT6EZQHC7","volume":"144","author":"SA Wang","year":"2015","unstructured":"Wang, S. A. & Hasserjian, R. P. Acute erythroleukemias, acute megakaryoblastic leukemias, and reactive mimics: a guide to a number of perplexing entities. Am. J. Clin. Pathol. 144, 44\u201360 (2015).","journal-title":"Am. J. Clin. Pathol."},{"key":"454_CR11","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1182\/blood-2009-10-249128","volume":"115","author":"MR Litzow","year":"2010","unstructured":"Litzow, M. R. et al. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 115, 1850\u20131857 (2010).","journal-title":"Blood"},{"key":"454_CR12","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1182\/blood-2011-05-355743","volume":"118","author":"S Mailankody","year":"2011","unstructured":"Mailankody, S. et al. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS). Blood 118, 4086\u20134092 (2011).","journal-title":"Blood"},{"key":"454_CR13","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/leu.2013.34","volume":"27","author":"LE Roeker","year":"2013","unstructured":"Roeker, L. E. et al. Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17\u2009315 patients. Leukemia 27, 1391\u20131393 (2013).","journal-title":"Leukemia"},{"key":"454_CR14","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood.2019003382","volume":"135","author":"C Maia","year":"2020","unstructured":"Maia, C. et al. Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma. Blood 135, 2375\u20132387 (2020).","journal-title":"Blood"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00454-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00454-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00454-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T15:42:41Z","timestamp":1669909361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00454-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["454"],"URL":"https:\/\/doi.org\/10.1038\/s41408-021-00454-y","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"assertion":[{"value":"3 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"63"}}